Josiah S. Irvin

Josiah Irvin is a health care regulatory and transactional attorney at Smith Anderson, advising health care providers, investors, and life sciences companies on compliance, enforcement, and transactional matters.

Josiah counsels physician practices and management companies, hospitals, long-term care providers, pharmacies, behavioral health organizations, and digital health and value-based care platforms on structuring transactions and commercial arrangements, federal and state fraud and abuse laws — including the Anti-Kickback Statute, Stark Law, and False Claims Act — and matters involving licensure, corporate practice of medicine, and reimbursement. He has particular experience designing management services organization (MSO) structures and physician alignment arrangements under North Carolina and national corporate practice of medicine requirements.

He also advises pharmaceutical and medical device manufacturers, contract research organizations, and digital health companies on regulatory compliance and transactional matters, including HIPAA, 42 CFR Part 2, information blocking, and data privacy and security requirements.

Prior to joining Smith Anderson, Josiah practiced in the health care group of an international law firm in Washington, D.C. and New York. He enjoys running, spending time with family and friends, rooting for the Tar Heels, and gardening.

Recognition

• Best Lawyers: Ones to Watch^® in America, Health Care Law (2026)
• North Carolina Super Lawyers Rising Star (2026)

Education

• Boston University School of Law, J.D., with Health Care concentration, magna cum laude, 2016
  • Articles Editor, Boston University Law Review     
• University of North Carolina at Chapel Hill, B.A., 2011
  • Phi Beta Kappa National Honors Society
  • Economics National Honors Society

Bar & Court Admissions

• Health Law Section, North Carolina Bar Association
• Board of Directors, North Carolina Society of Health Care Attorneys (2024-present)

• Represented a private equity fund in its acquisition of a leading contract research organization and contract development and manufacturing organization specializing in cell and gene therapy.
• Advised a growing health and home services organization in its acquisition of an organization providing home care services.
• Advised health care providers and insurers -value-based contracting, corporate governance, charitable organization requirements, formation of joint ventures, and value.
• Advised pharmaceutical manufacturers and other life science companies on Anti-Kickback Statute compliance.
• Counseled digital health companies and health care providers on HIPAA, information blocking and CCPA compliance.
• Counseled health care providers on responding to potential data security and privacy breaches.
• Advised private equity firms on investments in a variety of health care targets, including management services organizations, physician group practices, pharmacies, digital health companies, behavioral health providers and kidney care providers.
• Advised Fortune 500 insurance company on acquisition of a non-profit Medicaid health plan.
• Defended digital health company in connection with civil and criminal investigations by U.S. Department of Justice into alleged Medicare and Medicaid fraud and violations of the Anti-Kickback Statute.
• Defended Fortune 100 health care company in connection with investigations by a U.S. Attorney’s Office and state Attorneys General into alleged Medicare and Medicaid fraud.
• Managed all aspects of internal investigation of a health care system.
• Conducted an internal targeted compliance audit of a medical device manufacturer.